Search Results - Elisabetta Bugianesi

Refine Results
  1. 1
    Review article: steatosis, the metabolic syndrome and cancer

    Review article: steatosis, the metabolic syndrome and cancer by Elisabetta Bugianesi

    Published 2005
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

    EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action? by Elisabetta Bugianesi

    Published 2016
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome

    Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome by Federico Salamone, Elisabetta Bugianesi

    Published 2010
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    Should we undertake surveillance for HCC in patients with NAFLD?

    Should we undertake surveillance for HCC in patients with NAFLD? by Ramy Younes, Elisabetta Bugianesi

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    NASH in Lean Individuals

    NASH in Lean Individuals by Ramy Younes, Elisabetta Bugianesi

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    NAFLD/NASH

    NAFLD/NASH by Elisabetta Bugianesi, Salvatore Petta

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis

    Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis by Andrea Marengo, Chiara Rosso, Elisabetta Bugianesi

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Impact of <scp>PNPLA3 I148M</scp> on Clinical Outcomes in Patients With <scp>MASLD</scp>

    Impact of <scp>PNPLA3 I148M</scp> on Clinical Outcomes in Patients With <scp>MASLD</scp> by Salvatore Petta, Angelo Armandi, Elisabetta Bugianesi

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

    Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? by Ester Vanni, Elisabetta Bugianesi, Giorgio Maria Saracco

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Insulin resistance: A metabolic pathway to chronic liver disease

    Insulin resistance: A metabolic pathway to chronic liver disease by Elisabetta Bugianesi, Arthur J. McCullough, Giulio Marchesini

    Published 2005
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults

    Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults by Andrea Marengo, R. Ibrahim Kamal Jouness, Elisabetta Bugianesi

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

    Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers by Claudia Sanna, Chiara Rosso, M. Marietti, Elisabetta Bugianesi

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease

    Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease by Marta Guariglia, Francesca Saba, Chiara Rosso, Elisabetta Bugianesi

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

    Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? by Luca Valenti, Elisabetta Bugianesi, Utpal B. Pajvani, Giovanni Targher

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Management of non-alcoholic fatty liver disease

    Management of non-alcoholic fatty liver disease by Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, Giulio Marchesini

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease

    Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease by Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance

    An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance by Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Gender-dependent alterations in serum leptin in alcoholic cirrhosis

    Gender-dependent alterations in serum leptin in alcoholic cirrhosis by Arthur J. McCullough, Elisabetta Bugianesi, Giulio Marchesini, Satish C. Kalhan

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Prognostic significance of diabetes in patients with cirrhosis

    Prognostic significance of diabetes in patients with cirrhosis by Giampaolo Bianchi, Giulio Marchesini, Marco Zoli, Elisabetta Bugianesi, Andrea Fabbri, E Pisi

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention by Manuel Romero‐Gómez, Shira Zelber‐Sagi, Franz Martı́n, Elisabetta Bugianesi, Bernat Soria

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: